After propensity score matching (16,076 pairs) and 2.2 years mean follow-up duration, use of GLP1-RA in patients with moderate to advanced CKD was associated with lower annual rate of acute healthcare utilization and all-cause mortality
A key study showed that people using GLP-1 receptor agonists had fewer anxiety cases (2.13 per 1,000 person-years) than non-users
PT-141 is administered as a subcutaneous injection or nasal spray, taken 45 minutes to one hour before sexual activity, with doses typically ranging from 1mg to 2mg
Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia
Moreover, stimulation of LS GLP-1R neurons reduced food intake, both in an acute and chronic manner, while inhibition increased food intake [108,109]